## MNST: Monster Beverage Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 2.5% below STRENGTH zone (4.0-10.0%); PEG 1.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($71.63)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Assenagon Asset Management S.A. Increases Stake in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251217T083138 | Somewhat-Bullish | Relevance: 100%
- Assenagon Asset Management S.A. significantly increased its stake in Monster Beverage Corporation in Q3, now owning 0.31% of the company valued at $203.97 million. Despite recent insider selling, analysts maintain a "Moderate Buy" consensus rating with an average target price of $71.64. Monster Beverage reported strong Q3 earnings, beating estimates with $0.56 EPS and revenue of $2.20 billion, up 16.8% year-over-year.

**2. Monster Vs. Celsius: As Consumers Ditch Soda And Booze, Which Energy Drink’s Stock Is Winning?**
- Source: Stocktwits | 20251216T120833 | Somewhat-Bullish | Relevance: 100%
- As consumers increasingly opt for healthier beverage choices, the energy drink market is booming, with Monster and Celsius emerging as major contenders. While Monster offers stable leadership and global reach, Celsius is favored by analysts due to its aggressive growth and high potential despite a recent stock dip. Celsius's strategic acquisitions and strong revenue growth indicate it is currently outperforming Monster in stock performance.

**3. Corient Private Wealth LLC Has $98.17 Million Stock Holdings in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251216T104219 | Bullish | Relevance: 100%
- Corient Private Wealth LLC significantly increased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 101.8% during the second quarter, now owning 1,567,140 shares valued at approximately $98.17 million. Analysts maintain a "Moderate Buy" consensus with a $71.64 target price. Monster Beverage recently surpassed earnings estimates with an EPS of $0.56 and revenue of $2.20 billion, demonstrating strong financial performance.

**4. Goldman Sachs, Capital One Financial And A Consumer Defensive Stock: CNBC's 'Final Trades'**
- Source: Benzinga | 20251217T133515 | Somewhat-Bullish | Relevance: 88%
- Malcolm Ethridge of Capital Area Planning Group recommended Goldman Sachs (NYSE: GS) following its agreement to acquire Innovator Capital Management for $2.0 billion. Stephanie Link of Hightower Advisors suggested Capital One Financial (NYSE: COF), citing an Outperform rating and $270 price target from Wolfe Research. Joseph M. Terranova of Virtus Investment Partners selected Monster Beverage Corporation (NASDAQ: MNST), which received a maintained Buy rating and an increased price target of $82 from Stifel.

**5. Will Clorox's Pricing Power Hold as Consumer Elasticity Tightens?**
- Source: TradingView — Track All Markets | 20251216T170805 | Somewhat-Bullish | Relevance: 64%
- Clorox is facing a challenging consumer environment where pricing power is tested by value-seeking behavior. The company is adapting by using price pack architecture and targeted promotions, alongside expanding smaller pack sizes and offering dilutable cleaners, to maintain affordability while focusing on premium options for convenience. Despite these efforts, margin pressure continues due to higher costs and ERP-related disruptions, although the company's diversified strategy aims to maintain brand health and selective pricing resilience.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 7, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $87 | $82 | +6% |
| 2025-12-12 | Stifel | $82 | $78 | +5% |
| 2025-12-03 | Piper Sandler | $85 | $75 | +13% |
| 2025-12-03 | Wells Fargo | $83 | $75 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Buy |
| 2025-12-12 | Stifel | main | Buy |
| 2025-12-03 | Piper Sandler | main | Overweight |
| 2025-12-03 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.74M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 6.9% (+3.2%)
- Blackrock Inc.: 6.1% (+3.7%)
- State Street Corpora: 3.9% (+8.0%)
- Alliancebernstein L.: 3.1% (-13.5%)
- LOOMIS SAYLES & CO L: 2.8% (+1.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 7 raises (avg +13%) could attract flows.
- Momentum building: MRS_20 improving +5.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.76 elevated, pricing in significant growth expectations. Forward P/E 33.4x stretched relative to 13% growth. Quality metrics strong (ROE 26%, ROA 17%, margin 22%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.24). Analyst sentiment positive (7 raises, avg +13%). Insider buying signal ($0.7M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.6B |
| Beta | 0.48 |
| 52W Range | $45.70 - $76.28 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.76 |
| Forward P/E | 33.4 |
| Current P/E | 37.8 |
| YoY Growth | 13.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.3% to 2.5% (+5.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.55% (CS: 53) | Neutral |
| RSI_14 | 56.8 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.166x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $74.33
- **Stop Loss:** $71.63 (3.6% risk)
- **Target:** $77.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 399
- **Position Value:** $29,657.67
- **Portfolio %:** 29.66%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-26 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.53 | +9.2% |
| 2025Q2 | $0.48 | $0.50 | +4.1% |
| 2025Q1 | $0.46 | $0.45 | -2.7% |
| 2024Q4 | $0.40 | $0.28 | -29.9% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*